Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
4.030
-0.020 (-0.49%)
At close: Jul 17, 2026, 4:00 PM EDT
4.000
-0.030 (-0.74%)
After-hours: Jul 17, 2026, 6:25 PM EDT

Oramed Pharmaceuticals Revenue

In the year 2025, Oramed Pharmaceuticals had annual revenue of $2.00M.

Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
164.93M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.00M--
Dec 31, 2024---
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M1.80M199.00%
Dec 31, 2021904.00K-1.80M-66.56%
Aug 31, 20212.70M-7.00K-0.26%
Aug 31, 20202.71M7.00K0.26%
Aug 31, 20192.70M254.00K10.37%
Aug 31, 20182.45M-7.00K-0.29%
Aug 31, 20172.46M1.82M283.15%
Aug 31, 2016641.00K--
Aug 31, 2015---
Aug 31, 2014---
Aug 31, 2013---
Aug 31, 2012---
Aug 31, 2011---
Aug 31, 2010---
Aug 31, 2009---
Aug 31, 2008---
Aug 31, 2007---
Aug 31, 2006---
Aug 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alector18.42M
Caribou Biosciences11.20M
Innate Pharma10.57M
Equillium4.39M
Milestone Pharmaceuticals1.78M
Revenue Rankings

ORMP News

More News